SCHEMBL26435280

SCHEMBL26435280

c1ccc(-c2nc(-c3cccc4c3sc3ccccc34)nc(-c3cccc4ccc5ccccc5c34)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.42
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PARP14 Q460N5 1/20 0.37
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435320 0.97 ALOX5 (0.43) ALOX5MAPTSMN1; SMN2TSHRKDM4E
SCHEMBL26435288 0.97 ALOX5 (0.43) ALOX5MAPTSMN1; SMN2TSHRKDM4E
SCHEMBL23759412 0.96 ALOX5 (0.41) ALOX5MAPTSMN1; SMN2TSHRKDM4E
SCHEMBL22880012 0.95 ALOX5 (0.39) ALOX5MAPTSMN1; SMN2TSHRKDM4E
SCHEMBL26435321 0.94 ALOX5 (0.43) ALOX5MAPTSMN1; SMN2TSHRKDM4E
SCHEMBL25621607 0.94 ALOX5 (0.40) ALOX5MAPTSMN1; SMN2TSHRKDM4E
SCHEMBL24473177 0.94 ALOX5 (0.40) ALOX5MAPTSMN1; SMN2TSHRKDM4E
SCHEMBL26435291 0.94 ALOX5 (0.41) ALOX5MAPTSMN1; SMN2TSHRKDM4E
SCHEMBL26435298 0.93 ALOX5 (0.43) ALOX5MAPTTSHRALDH1A1HPGD
SCHEMBL24034458 0.93 ALOX5 (0.39) ALOX5MAPTSMN1; SMN2TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885MAPT 2425/4885SMN1; SMN2 2642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.